Cruz, E., Sifniotis, V., Sumer-Bayraktar, Z., Reslan, M., Wilkinson-White, L., Cordwell, S., & Kayser, V. (2021). Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. Pharmaceutics, 13(11), 1747. https://doi.org/10.3390/pharmaceutics13111747
Chicago Style (17th ed.) CitationCruz, Esteban, Vicki Sifniotis, Zeynep Sumer-Bayraktar, Mouhamad Reslan, Lorna Wilkinson-White, Stuart Cordwell, and Veysel Kayser. "Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity." Pharmaceutics 13, no. 11 (2021): 1747. https://doi.org/10.3390/pharmaceutics13111747.
MLA (9th ed.) CitationCruz, Esteban, et al. "Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity." Pharmaceutics, vol. 13, no. 11, 2021, p. 1747, https://doi.org/10.3390/pharmaceutics13111747.